Thomas Andreas Forst MD

Professor Thomas Andreas Forst is a certified physician for internal medicine and endocrinology. In 1989, he started his postdoctoral clinical research work at the German Diabetes Research Institute (Leibnitz Institute) at Heinrich Heine University in Düsseldorf, Germany. In 1999, he completed his academic training in Internal Medicine and Endocrinology at the 3rd Medical Department for Internal Medicine at the Johannes Gutenberg University in Mainz, Germany. Thereafter, he served as a Clinical Research Physician at Eli Lilly Indianapolis and was responsible for several clinical trials with new drugs for the treatment of diabetes mellitus and its vascular complications.

In 2001 he took over the position of the CEO and Medical Director of a clinical research unit with a special alignment to diabetes and metabolic research (Institute for Clinical Research and Development, Mainz, Germany). In March 2013, Professor Forst joined the Profil Institute, where he established a new clinical research unit in the city of Mainz. Until the end of 2017, he served as the CEO and Director for Medical Science at the Profil Institute Mainz. In January 2018 Professor Forst joined Clinical Research Services Andernach, Germany, where he serves as the Chief Medical Officer.

Since 2001 Professor Forst is a teaching professor for Internal Medicine and Endocrinology at the Johannes Gutenberg University in Mainz. Within the last 30 years, Professor Forst was involved in more than 300 clinical trials mainly in the area of metabolic diseases. Professor Forst joins the board of the study group of neuropathy and the study group of cardiovascular disease of the German Diabetes Association. Professor Forst is a member of the Editorial Board of several national and international trade journals. He acts as the chief editor of the Diabetes Congress Report. Professor Forst has authored or co-authored in excess of two-hundred-fifty original articles in peer-reviewed National and International Journals.